Chemed (CHE)
(Delayed Data from NYSE)
$548.91 USD
-0.42 (-0.08%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $549.66 +0.75 (0.14%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
CHE 548.91 -0.42(-0.08%)
Will CHE be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CHE
Chemed (CHE) Down 3.1% Since Last Earnings Report: Can It Rebound?
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
EHC or CHE: Which Is the Better Value Stock Right Now?
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Chemed (CHE) Q1 Earnings Miss Estimates
Other News for CHE
Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference
China Huarong Sells Majority Stake
China CITIC Financial’s Resolutions Pass with Strong Support
Dividend Champion, Contender, And Challenger Highlights: Week Of May 26
Chemed price target lowered by $15 at RBC Capital, here's why